Rethinking the Antibiotic Discovery Paradigm

EBioMedicine

Volumn 2, Issue 7, 2015, Pages 629-630

  Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; AZITHROMYCIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLISTIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BIOFILM; CATHETER INFECTION; DRUG DEVELOPMENT; HUMAN; IMMUNE DEFICIENCY; INFECTION; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; NOTE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; ANIMAL; DRUG EFFECTS; FEMALE; GRAM NEGATIVE BACTERIUM; MULTIDRUG RESISTANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; AZITHROMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 84951573445     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.010     Document Type: Note

References (8)

1. Fuente-Núñez C., Reffuveille F., Fernández L., Hancock R.E.W. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 2013, 16:580-589.
2. Gill E.E., Franco O.L., Hancock R.E.W. Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem. Biol. Drug Des. 2015, 85:56-78.
3. Hancock R.E.W., Nijnik A., Philpott D.J. Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microbiol. 2012, 10:243-254.
4. Lin L., Nonejuie P., Munguia J., Hollands A., Olson J., Dam Q., Kumaraswamy M., Rivera H., Corriden R., Rohde M., Hensler M.E., et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. eBiomedicine 2015, (http://dx.doi.org/10.1016/j.ebiom.2015.05.021).
5. Nigama A., Guptab D., Sharma A. Treatment of infectious disease: beyond antibiotics. Microbiol. Res. 2014, 169:643-651.
6. Pena O.M., Hancock D.G., Lyle N.H., Linder A., Russell J.A., Xia J., Fjell C.D., Boyd J.H., Hancock R.E.W. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. eBiomedicine 2014, 1:64-71.
7. Singh S.B. Confronting the challenges of discovery of novel antibacterial agents. Bioorg. Med. Chem. Lett. 2014, 24:3683-3689.
8. Wiegand I., Hilpert K., Hancock R.E.W. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 2008, 3:163-175.